PDCD1 and neoplasm: Nevertheless, it is also important to consider the role of immune response suppressor cells or immune checkpoint pathways as targets to overcome the tumor-induced immunosuppression, such as MDSCs [47], Tregs [48], or both PD-1 and CTLA-4 pathways [49,50].